Sarepta Therapeutics Inc (SRPT)
118.97
-0.50
(-0.42%)
USD |
NASDAQ |
Dec 20, 16:00
119.11
+0.14
(+0.12%)
After-Hours: 20:00
Sarepta Therapeutics Market Cap: 11.36B for Dec. 20, 2024
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Arrowhead Pharmaceuticals Inc | 2.422B |
| Eli Lilly and Co | 728.85B |
| Alnylam Pharmaceuticals Inc | 31.66B |
| Catalyst Pharmaceuticals Inc | 2.537B |
| Vertex Pharmaceuticals Inc | 102.31B |
Market Cap Related Metrics
| PE Ratio | 77.25 |
| PS Ratio | 7.298 |
| Price to Book Value | 9.307 |
| Price | 118.97 |
| Earnings Yield | 1.29% |
| Operating PE Ratio | 147.74 |
| Normalized PE Ratio | 72.93 |